GENE ONLINE|News &
Opinion
Blog

Chronic Kidney Disease
GSK’s Jesduvroq Wins FDA Approval for First Oral Drug for Anemia In Chronic Kidney Disease
2023-02-02
Highlights of ASN Kidney Week 2022
2022-11-02
AstraZeneca’s Treatment for Chronic Kidney Disease Wins Yet Another Approval
2022-09-05
Amgen Out-Licenses Two Therapies to Fosun Pharma to Expand Presence in China
2022-06-28
EU Greenlight for Bayer’s Kidney Disease Drug, Kicking off Market Rivalry Against Established SGLT-2 Inhibitors 
2022-03-01
Australia’s CSL Makes $11.7 Billion Bid for Swiss Drugmaker Vifor
2021-12-15
FDA Okays Bayer’s Kidney Disease Drug, Kicking Off Market Rivalry Against Established SGLT-2 Inhibitors
2021-07-12
FDA Greenlights AstraZeneca’s Blockbuster Drug for Chronic Kidney Disease
2021-05-02
China’s NMPA Greenlights LOKELMA Label Update for Haemodialysis, Hyperkalaemia Patients
2020-11-27
Multifaceted Farxiga Shows Benefit in Chronic Kidney Disease
2020-07-30
LATEST
Eli Lilly Breaks Records with $9B Total Investment in Indiana Weight-loss Drug Expansion
2024-05-27
New Regulatory Measures in China A First in the Fight Against Sedentary Behavior in Children
2024-05-24
Cure Genetics Announced Promising Safety and Efficacy Data of CAR-NKT Product CGC729 for RCC at ASGCT 2024
2024-05-23
AstraZeneca’s $1.5 Billion ADC Manufacturing Facility in Singapore
2024-05-23
Hims & Hers Health Inc. Tipping the Scales of the Weight Loss Market — and Wall Street is Loving it!
2024-05-22
GV Announces Cooperation with CICC
2024-05-22
Eli Lilly and Aktis Oncology Partner to Advance Novel Radiopharmaceuticals
2024-05-22
EVENT
Scroll to Top